Back to search
Radioactive Iodine-refractory Differentiated Thyroid Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Radioactive Iodine-refractory Differentiated Thyroid Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Radioactive Iodine-refractory Differentiated Thyroid Cancer trials you may qualify forCABOTHYROID is a prospective, exploratory, biomarker-focused, phase II, single-arm, non-randomized, non-blinded, investigator-initiated study of cabozantinib in…
This is a multicentric prospective non-randomized phase II trial, with two independent arms: one for patients with RAS mutation and one for patients with BRAFV6…
This is a single arm, open-label, non-randomized and single-center phase II clinical study, to evaluate the safety, tolerance, and efficacy of Camrelizumab in c…